L'Universite Montpellier II

Patent Applications and Registrations

Patent applications and USPTO patent grants for L'Universite Montpellier II.The latest application filed is for "modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections".

Company Profile

0.15.5

L'Universite Montpellier II - Montpellier N/A FR
L'Universite Montpellier II - Cagliari IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
.beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B Grant 9,290,533 - Gosselin , et al. March 22, 2	2016-03-22
Purine nucleoside analogues for treating flaviviridae including hepatitis C Grant 9,186,369 - Storer , et al. November 17, 2	2015-11-17
Modified 2' And 3'-nucleoside Prodrugs For Treating Flaviviridae Infections App 20150017124 - STORER; Richard ; et al.	2015-01-15
Purine Nucleoside Analogues For Treating Flaviviridae Including Hepatitis C App 20140234251 - STORER; Richard ; et al.	2014-08-21
Modified 2' And 3'-nucleoside Prodrugs For Treating Flaviviridae Infections App 20140213540 - STORER; Richard ; et al.	2014-07-31
Purine nucleoside analogues for treating flaviviridae including hepatitis C Grant 8,742,101 - Storer , et al. June 3, 2	2014-06-03
Modified 2' And 3'-nucleoside Prodrugs For Treating Flaviviridae Infections App 20140113880 - Storer; Richard ; et al.	2014-04-24
Beta-l-2'-deoxy-nucleosides For The Treatment Of Hepatitis B App 20130324491 - Gosselin; Gilles ; et al.	2013-12-05
Compounds and pharmaceutical compositions for the treatment of viral infections Grant 7,951,789 - Sommadossi , et al. May 31, 2	2011-05-31
Compounds and pharmaceutical compositions for the treatment of viral infections Grant 7,902,202 - Sommadossi , et al. March 8, 2	2011-03-08
.beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B Grant 7,795,238 - Gosselin , et al. September 14, 2	2010-09-14
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,662,798 - LaColla , et al. February 16, 2	2010-02-16
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,635,689 - LaColla , et al. December 22, 2	2009-12-22
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections Grant 7,625,875 - Gosselin , et al. December 1, 2	2009-12-01
3'-prodrugs of 2'-deoxy-.beta.-L-nucleosides Grant 7,585,851 - Bryant , et al. September 8, 2	2009-09-08
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections Grant 7,582,618 - Sommadossi , et al. September 1, 2	2009-09-01
.beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B Grant 7,304,043 - Gosselin , et al. December 4, 2	2007-12-04
.beta.-L-2'-deoxy-nucleosides for the treatment of hepatitis B Grant 6,946,450 - Gosselin , et al. September 20, 2	2005-09-20
3'-prodrugs of 2'-deoxy-.beta.-L-nucleosides Grant 6,875,751 - Imbach , et al. April 5, 2	2005-04-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.